Novo Integrated Sciences Inc (NVOS) Fair Value & Analysis

Healthcare · US · Market cap $13.8K

Below-average quality, screening 41% undervalued on our models.

What matters now

• The large discount to fair value meets weak quality (27/100). That raises the risk this is a value trap rather than a bargain.
• The price is below even our cautious bear case ($0.0031). The market is more pessimistic than our downside scenario.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 31, 2026.

How to read this chart

60‑month range $0.0001 – $30.90 · the $0.0022 price screens below the $0.0031 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 31, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Novo Integrated Sciences Inc (NVOS) currently trades at $0.0022, while our model-based Fair Value estimate is $0.0031, implying the stock looks roughly 40.9% undervalued today. The Quality Score stands at 27/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Trailing-twelve-month revenue stands at $13.3M. Revenue declined 6.7% year over year. It earns a return on equity of -82.5%. Net debt stands at $3.9M. Fundamentals as of Jul 31, 2026

For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at 41%, NVOS screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Key figures & financial health

Quality Score breakdown

About the company

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales.

Full company description

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training services through clinics. It also provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services through long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology platforms, such as Novo Connect, telemedicine/telehealth, and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

Novo Integrated Sciences Inc reported revenue of $13.3M in FY2024 versus $7.9M in FY2020, a compound +14.0%/yr. Reported net income was −$16.1M in FY2024.

Watch NVOS: get an alert when its fair value changes →

Peer Group

Medical Care Facilities · 267 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.